Environmental estrogens (xenoestrogens) are synthetic compounds that are abundant in the environment and mimic natural estrogens. The estrogenicity of two such compounds, bisphenol A (BPA) and octylphenol (OP), during development of the neuroendocrine system was investigated. The objective was to compare the effects of neonatal exposure to BPA, OP, and diethylstilbestrol (DES), a potent synthetic estrogen, on prepubertal serum PRL levels and estrogen receptor (ER) expression in the anterior pituitary and medial basal hypothalamus. Receptor expression in the uterus and prostate, two peripheral estrogen-responsive tissues, was also examined. Newborn male and female Fischer 344 rats were sc injected on days 1-5 after birth with corn oil (control), BPA and OP (100 or 500 g/day), or DES (5 g/day). Rats were bled on days 15, 20, and 25 and on the day of death (day 30), and serum PRL was analyzed by RIA. Relative expressions of ER␣ and ER␤ were determined by RT-PCR. BPA and OP induced delayed, but progressive, increases in serum PRL levels, up to 3-fold above control levels, in both males and females. The low dose of either compound was equally or more effective as the high dose in eliciting and sustaining elevated serum PRL levels, namely hyperprolactinemia. In contrast, the DES treatment resulted in a transient rise in serum PRL levels. BPA, OP, and, to a lesser extent, DES increased the expression of both ER␣ and ER␤ in the anterior pituitary of males, but not females, whereas the hypothalamic ERs were less responsive to these compounds. DES treatment caused downregulation of ER␣ expression in the uterus and up-regulation of ER␤ in the prostate, whereas BPA or OP was without effect. In conclusion, exposure of newborn rats of either sex to environmental estrogens results in delayed and sustained hyperprolactinemia and differential alterations in ER expression in the hypothalamus and pituitary. DES appears to target the lower reproductive tract more effectively than the neuroendocrine system. (Endocrinology 141: [4512][4513][4514][4515][4516][4517] 2000) E NVIRONMENTAL estrogens (xenoestrogens) are a diverse group of synthetic compounds that are abundant in the environment and mimic the action of estrogens. Two such compounds, bisphenol A (BPA) and octylphenol (OP), were the focus of this investigation (Fig. 1) . BPA is composed of two unsaturated phenolic rings that resemble diethylstilbestrol (DES). BPA is a monomer of polycarbonate plastics and a constituent of epoxy and polystyrene resins used in the food packaging industry and dentistry (1, 2). The polymer bonds can hydrolyze at high temperature and release BPA. Detectable amounts of BPA were found in food cans (3), microwaved pizzas (4), and human saliva after treatment with dental sealants (5). OP, comprised of a single phenolic ring (Fig. 1) , is a constituent of alkylphenol polyethoxylates that are used as surfactants in detergents, paints, and herbicides. Alkylphenols are degraded in treatment plants to form stable products, OP and nonylphenol, which are hydrophobic and can accumulate in sewage sludge (6). Within internal organs of fish and birds, these compounds can reach a 10 -100 times higher concentration than in the environment and thus can pass through the food chain to humans.
OP induced delayed, but progressive, increases in serum PRL levels, up to 3-fold above control levels, in both males and females. The low dose of either compound was equally or more effective as the high dose in eliciting and sustaining elevated serum PRL levels, namely hyperprolactinemia. In contrast, the DES treatment resulted in a transient rise in serum PRL levels. BPA, OP, and, to a lesser extent, DES increased the expression of both ER␣ and ER␤ in the anterior pituitary of males, but not females, whereas the hypothalamic ERs were less responsive to these compounds. DES treatment caused downregulation of ER␣ expression in the uterus and up-regulation of ER␤ in the prostate, whereas BPA or OP was without effect. In conclusion, exposure of newborn rats of either sex to environmental estrogens results in delayed and sustained hyperprolactinemia and differential alterations in ER expression in the hypothalamus and pituitary. DES appears to target the lower reproductive tract more effectively than the neuroendocrine system. (Endocrinology 141: [4512] [4513] [4514] [4515] [4516] [4517] 2000) E NVIRONMENTAL estrogens (xenoestrogens) are a diverse group of synthetic compounds that are abundant in the environment and mimic the action of estrogens. Two such compounds, bisphenol A (BPA) and octylphenol (OP), were the focus of this investigation (Fig. 1) . BPA is composed of two unsaturated phenolic rings that resemble diethylstilbestrol (DES). BPA is a monomer of polycarbonate plastics and a constituent of epoxy and polystyrene resins used in the food packaging industry and dentistry (1, 2) . The polymer bonds can hydrolyze at high temperature and release BPA. Detectable amounts of BPA were found in food cans (3), microwaved pizzas (4) , and human saliva after treatment with dental sealants (5) . OP, comprised of a single phenolic ring ( Fig. 1) , is a constituent of alkylphenol polyethoxylates that are used as surfactants in detergents, paints, and herbicides. Alkylphenols are degraded in treatment plants to form stable products, OP and nonylphenol, which are hydrophobic and can accumulate in sewage sludge (6) . Within internal organs of fish and birds, these compounds can reach a 10 -100 times higher concentration than in the environment and thus can pass through the food chain to humans.
Various in vitro assays have established that OP and BPA are rather weak estrogens, with a 5,000-to 10,000-fold lower binding affinity to the estrogen receptor (ER) than estradiol or DES (7) (8) (9) . However, we recently reported pronounced in vivo estrogenic effects of BPA that were higher than expected from its weak in vitro estrogenicity. Our data revealed transient hyperprolactinemia (10) and marked hypertrophy and hyperplasia in the uterus and vagina (11) of adult female Fischer 344 (F344) rats treated with modest doses of BPA. Blake and co-workers reported that OP given to adult male rats caused alterations in gonadotropin release (12) and testicular shrinkage (13) .
Whereas gonadal steroids act as reversible regulatory agents in the adult, they function as organizational agents during fetal development. Inappropriate exposure of the developing fetus to exogenous estrogens can cause long-term deleterious effects. A case in point is the consequence of treating millions of pregnant women with DES in the 1950 -1960s to prevent miscarriage. In utero exposure to DES resulted in lower fertility, reproductive tract anomalies, and increased incidence of vaginal adenocarcinoma in women and urogenital tract deformities, cryptorchidism, and reduced fertility in men (14) . Subsequent work with laboratory animals, primarily rodents, established that prenatal or early postnatal exposure to DES induces numerous structural and functional abnormalities in estrogen-responsive tissues (15) . Rodents are especially well suited for studying the developmental effects of xenoestrogens because they can be treated during the first few days of life, when their maturity level resembles that of a second trimester human embryo. Recent reports reveal that prenatal exposure of mice to BPA advanced the onset of puberty in females (16) and caused prostate enlargement in males (17) , whereas exposure of newborn rats to OP caused disruption of estrous cyclicity (18) .
The pituitary lactotroph is an established target of estrogen. Estrogens can affect PRL release by acting directly on the lactotrophs or indirectly on the hypothalamic dopaminergic system as well as on a variety of PRL secretagogues of hypothalamic or pituitary origin (19) . As the neuroendocrine system that regulates PRL is immature at birth, it was of interest to determine whether neonatal exposure to xenoestrogens induces prolonged alterations in PRL release. Another question was whether xenoestrogens affect the expression of ERs in the neuroendocrine axis. Indeed, OP and BPA bind to ER␣ and ER␤ (7), both of which are expressed in the rat anterior pituitary (AP) (20) and medial basal hypothalamus (MBH) (21) . In addition, two truncated estrogen receptor products, named TERP1 and TERP2, are unique to the pituitary (22) and are up-regulated by estrogens (20, 23) .
Our specific objective was to compare the effects of treating newborn male and female rats with BPA, OP, and DES on plasma PRL levels and ER expression in the AP and MBH before puberty. For comparison, ER expression in the uterus and prostate was also determined. F344 rats were exclusively used because of their recognized sensitivity to xenoestrogens (10, 24) .
Materials and Methods Animals
All animal experiments were carried out under institutionally approved protocols according to USPHS guidelines for the care and use of laboratory animals. Pregnant Fischer 344 rats (Harlan Sprague Dawley, Inc., Indianapolis, IN) were maintained in individual cages on a 12-h light, 12-h dark schedule and received food and water ad libitum. The day of birth was considered postnatal day 0.
Experimental paradigm
A flow diagram of the experimental protocol is shown in Fig. 2 . All treatments started on postnatal day 1. On days 1-5 of life, each pup received a sc injection of either 50 l tocopherol-stripped corn oil (control) or solutions of BPA (Aldrich, Milwaukee, WI), OP (Aldrich), or DES (Sigma, St. Louis, MO) in corn oil. Two doses of BPA and OP (100 and 500 g/day) and a single dose of DES (5 g/day) were used. Each treatment group included 8 -10 male or female pups.
Blood collection and tissue removal
Pups were bled from the tail vein by tail clipping on days 15, 20, and 25, taking care not to stress the animals. Serum was separated by centrifugation and kept at Ϫ70 C until analyzed for PRL by RIA. Animals were killed by decapitation on day 30, and trunk blood was collected for PRL analysis. MBHs, APs, uteri, and prostates were quickly removed, frozen on dry ice, and stored at Ϫ70 C.
Determination of serum PRL by RIA
A modified PRL RIA was employed (25) , using the NIDDK kit with RP-3 rat PRL as a reference preparation. Briefly, serum aliquots (10 -20 l), diluted in 100 l PBS containing 0.1% BSA, were incubated with 50 l antirat PRL antibody (1:40,000) and 50 l iodinated rat PRL in 96-well plates. After a 2-day incubation at 4 C, the PRL-antibody complexes were precipitated by the addition of 50 l protein A, followed by centrifugation at 3,000 ϫ g for 10 min. The supernatants were aspirated, and the pellets were dissolved in 20 l 0.1 n NaOH. After adding 200 l scintillation fluid (Microscint 20, Packard Instruments, Downers Grove, IL), radioactivity was determined in a Packard TopCount. The limit of sensitivity of the assay was 100 pg/well.
Analysis of ER expression by RT-PCR
Total RNA was isolated from each tissue using Tri-Reagent (Life Technologies, Inc., Gaithersburg, MD), and 5 g were reversed transcribed using Superscript II reverse transcriptase and random hexamers (Life Technologies, Inc.) as previously described (20) . Optimal PCR conditions for quantitation were established for each set of primers by varying the cycle number, annealing temperature, and RNA concentrations. Final conditions for all estrogen receptors were as follows: 1) ER␣, 200 ng RNA amplified at 58 C for 26 cycles; 2) ER␤, 200 ng RNA amplified at 60 C for 35 cycles; and 3) TERP, 500 ng amplified at 55 C for 28 cycles. Each PCR reaction also contained primers for ribosomal protein L19 (L19), which served as an internal control.
Primer sequences and expected product sizes were as follows: ER␣: sense primer, 5Ј-GCTCCA ATTCTGACAATCGAC-3Ј; antisense primer, 5Ј-TTTCGTATCCCGCCTTTCATC-3Ј (expected size of 308 bp); ER␤: sense primer, 5Ј-AACCTCAA AAGAGTCCTTGGTGTG-3Ј; antisense primer, 5Ј-AACACTTGCGAAGTCGGCAG-3Ј (expected size of 327 bp); TERP: sense primer, 5Ј-GCTTGTTGAACAGCGACCAG-3Ј; antisense primer, 5Ј-CTTGT CCAGGACTCGGTGG-3Ј (expected size of 366 bp for TERP 1 and 432 bp for TERP 2); L19 for ER␣: sense primer, 5Ј-AGTAT-GCTTAGGCTACAGAAG-3Ј; antisense primer, 5Ј-TTCCTTGGTCTTA-GACCTGCG-3Ј (expected product size of 500 bp); and L19 for ER␤ and TERP: sense primer, 5Ј-CGAAATCGCCAATGCCAACTC-3Ј; antisense primer, 5Ј-TGCTCC ATGAGAATCCGCTTG-3Ј (expected product size of 333 bp).
The PCR products were separated on a 1.5% agarose gel stained with ethidium bromide and analyzed by scanning densitometry (Chemi Doc, Bio-Rad Laboratories, Inc., Hercules, CA). A representative example of PCR optimization for ER␣, using anterior pituitary RNA from female pups, is shown in Fig. 3 . Note the linear increase in the ODs of both ER␣ and L19 between 60 and 500 ng RNA at 26 cycles. A similar linearity was established for each ER.
Data analysis
Results are expressed as the mean Ϯ sem. For the PCR analysis, the density ratio of the bands for ER/L19 was determined for each sample, and the results are expressed as a percentage of the control values (rats treated with corn oil). Statistical differences were determined using ANOVA followed by Student-Newman-Keuls test (SigmaStat 4.0, Jandel Corp., San Raffael, CA).
Results

Hyperprolactinemia in females
As shown in Fig. 4 , serum PRL levels in the controls increased from 10 ng/ml on day 15 to 22 ng/ml on day 20 and remained unchanged to day 30, whereas all females treated with BPA, OP, or DES became hyperprolactinemic. Serum PRL levels progressively increased from days 20 to 30 in response to treatment with BPA or OP. The maximal rise in serum PRL levels (3-fold above controls; P Ͻ 0.05) was observed in the OP-treated group. Notably, the lower dose of OP (100 g/pup⅐day) was as effective as the higher dose (500 g/pup⅐day) in stimulating and sustaining elevated serum PRL levels. A similar response was observed in the BPAtreated group (Fig. 4) . On the other hand, circulating PRL levels in the DES-treated group (5 g/pup⅐day) were already elevated on day 15 (P Ͻ 0.05) and peaked 3-fold above controls on day 25 (P Ͻ 0.05), but declined to control levels on day 30.
Hyperprolactinemia in males
Serum PRL levels in control males rose from 18 ng/ml on day 15 to 30 ng/ml on day 25 without a significant change on day 30 (Fig. 5) . As in females, hyperprolactinemia was observed in all males treated with BPA, OP, or DES. Peak serum PRL levels (2-to 3-fold above control values) were reached on day 25 in the groups treated with the lower dose of BPA and OP and remained elevated on day 30. The higher doses of these compounds caused similar or lower increases Rats were treated on days 1-5 of life with 100 g/day (F) or 500 g/day (OE) BPA or OP or with 5 g/day DES (f). Control rats (E) were injected with corn oil. Blood was collected on the designated days and analyzed for PRL by RIA. Each value is the mean Ϯ SEM of 8 -10 serum samples. Note that the low dose of BPA or OP was as effective as the higher dose in eliciting hyperprolactinemia. in serum PRL. Similar to females, newborn males treated with DES had elevated serum PRL levels that peaked on day 25 (P Ͻ 0.05) and declined to control levels on day 30.
Expression of ER␣
As the low dose of BPA or OP was as effective as the high dose in inducing hyperprolactinemia, ER expression was analyzed only in tissues obtained from low dose-treated rats. Both BPA and OP, but not DES, induced a small increase (P Ͻ 0.05) in hypothalamic ER␣ expression in females (Fig. 6 ) without a significant change in pituitary ER␣. DES, but not BPA or OP, caused a 30% reduction (P Ͻ 0.05) in uterine ER␣ expression. In males, hypothalamic ER␣ expression decreased in response to DES only (P Ͻ 0.05), whereas that in the AP increased in all treatment groups (Fig. 7) . Maximal stimulation (2.5-fold above controls; P Ͻ 0.05) was seen in the AP of OPtreated males. Unlike its lack of effects in females, DES significantly (P Ͻ 0.05) increased ER␣ expression in the AP of males.
Expression of ER␤
The expression of ER␤ was unchanged in all female tissues examined (data not shown). In males, both OP and BPA caused 35-40% increases (P Ͻ 0.05) in pituitary ER␤ expression (Fig. 8) , but did not affect the hypothalamus (data not shown). Among the three treatment groups, DES was the least effective on pituitary ER␤ expression. Treatment with DES resulted in more than a 2-fold (P Ͻ 0.05) increase in ER␤ expression in the prostate (Fig. 8) , whereas BPA and OP were ineffective.
Expression of TERP
As we previously reported that estrogen up-regulates TERP messenger RNA expression in the adult AP (20), we examined its expression in the neonates. As shown in Fig. 9 , TERP messenger RNA was undetectable in the AP of all samples tested, whereas under identical conditions both isoforms of TERP were detected in pituitary tissue from adult, estrogen-treated ovariectomized F344 rats.
Discussion
We report prolonged estrogenic effects of OP and BPA within the neuroendocrine axis of prepubertal F344 rats. Serum PRL levels in xenoestrogen-treated rats of both sexes began to increase after day 20 and remained elevated on day 30 of life. A lower dose of either compound (100 g/pup⅐day) 2 and 3) or DES-treated (lanes 4 and 5) neonatal females. On the other hand, both TERP1 and TERP2 were observed in AP taken from estrogen-treated adult females (lanes 6 and 7). Lane 1, 100-bp standards.
was as effective as a 5-fold higher dose in inducing hyperprolactinemia. Serum PRL levels in the animals treated with DES (5 g/pup⅐day) were initially elevated, but were not sustained. BPA and OP increased the expression of ER␣ and ER␤ in the male, but not the female, pituitary with no effect on the hypothalamus. DES significantly decreased ER␣ expression in the uterus and increased ER␤ in the prostate, but, in general, had lesser effects on receptor expression in the hypothalamo-pituitary axis.
There is substantial evidence that prenatal and neonatal exposure of male and female rodents to DES, a very potent synthetic estrogen, causes multiple disturbances in the reproductive tract (15, 26) . Although increased PRL release is a well characterized effect of estrogens, serum PRL levels in adult mice, neonatally treated with DES, were unchanged (27, 28) . These reports agree with our observation that DES, at a dose similar to that used by others (27) (28) (29) (30) , causes only a transient rise in serum PRL levels in prepubertal male and female rats. Despite having a 10,000-fold higher binding affinity to the ER than the xenoestrogens, DES had only modest effects on receptor expression in the neuroendocrine system. On the other hand, it down-regulated ER␣ expression in the uterus, consistent with a previous report (31) , and up-regulated ER␤ expression in the prostate; neither BPA nor OP affected ER expression in these tissues. This together with its inability to sustain hyperprolactinemia suggest that DES targets the lower reproductive tract more effectively than the neuroendocrine axis, although the effect of yet a lower dose of DES has not been determined. Nonetheless, it should be noted that hyperprolactinemia has not been observed in either humans or experimental animals exposed to various doses of DES in utero.
The issues of doses and binding affinities to the ERs are at the heart of the controversy regarding xenoestrogens. In the absence of information on the pharmacokinetics of these compounds, it is difficult to estimate the doses that simulate environmental exposure levels. A number of factors can enhance the in vivo effectiveness of xenoestrogens. These include prolonged storage in body fat (32) , conversion to active metabolites (33) , resistance to degradation, or low binding to serum proteins (17) . There is an urgent need for developing methods for assessing the bioavailability of these compounds in both humans and experimental animals. Based on the knowledge that xenoestrogens have low binding affinity to the ER in vitro, many investigators have treated experimental animals with exceedingly high doses (34) . However, high and low doses of estrogens often result in opposite effects (35, 36) . Our study reveals that the low dose of either BPA or OP was equally or more effective as the high dose. Perhaps an even lower dose can elicit significant estrogenic responses.
The maturation of the PRL regulatory apparatus in rats is delayed until after birth (37) (38) (39) . During the first few weeks of life, the number of lactotrophs (40) , PRL gene expression (41) , and circulating PRL levels (42, 43) progressively increase. Sexual dimorphism, e.g. higher PRL production and increased lactotroph responsiveness to secretagogues in females than in males, is established during puberty. To examine xenoestrogen-induced changes in serum PRL levels with a minimal exposure to endogenous steroids, the experiment was terminated on prepubertal day 30. Therefore, we do not know whether the xenoestrogen-induced hyperprolactinemia persists beyond this age and whether it affects the onset of puberty or fertility in either sex. These issues should be addressed in future experiments.
The mechanisms underlying the delayed and sustained hyperprolactinemia in prepubertal rats may be complex. It is unlikely that xenoestrogens remain in the circulation for 4 weeks and continuously stimulate the lactotrophs. The levels of endogenous estrogens, especially in prepubertal males, are probably too low to elicit such a response unless some target cells become hypersensitive to their action. We speculate that the observed hyperprolactinemia is caused by xenoestrogen-induced reprogramming effects in one or more components of the PRL regulatory system. These include decreased dopamine biosynthesis, decreased density of dopamine D 2 receptors on the lactotrophs, increased number of lactotrophs, and/or increased production of certain PRLregulating factors from the hypothalamus or pituitary. Studies focusing on possible xenoestrogen-induced alterations in these components are underway.
Our second objective was to determine whether neonatal exposure to xenoestrogens elicits long-term changes in ER expression. Estrogens are known to down-regulate their receptors in the uterus and up-regulate those in the pituitary (22) . Given the minute size of the AP and MBH, the low level of ER expression in these tissues, and the large number of samples, our approach for examining ER expression was limited to RT-PCR. The data reveal gender differences in both the site and the magnitude of the response to xenoestrogens. In females, BPA and OP caused small increases in ER␣ expression in the MBH, but not the AP, and did not affect ER␤ expression in any tissue examined. In males, these compounds increased both ER␣ and ER␤ expression in the pituitary without affecting the hypothalamus. Whereas these results indicate a higher responsiveness of the male pituitary to xenoestrogens, neither the identity of the target cells nor the mechanisms underlying gender differences are well understood.
Our hypothesis is that premature exposure to xenoestrogens alters the lactotrophs themselves, their regulatory systems, or both. As is inherent to all endocrine systems, perturbations at one site trigger compensatory mechanisms aimed at minimizing the disturbance. Although this is true for the adult organism with a fully developed negative feedback system, this mechanism may be imperfect in the very young who are still in the processes of developing homeostasis. Additionally, because of the diversity of xenoestrogens and the existence of tissue-specific ER coactivators (44), each compound can exert different effects on the various estrogenresponsive cells. As is the case with the tissue-specific agonist/antagonist actions of tamoxifen (45) , some xenoestrogens may even antagonize the action of endogenous estrogens at certain sites.
In summary, this is the first report of induction of hyperprolactinemia after early exposure of rats to environmental estrogens. These observations may have some implications to human hyperprolactinemia, especially if there is a human homolog of the sensitive F344 rat. Hyperprolactinemia is associated with infertility in women and impotence in men. As concluded from several prospective studies, there is no clear correlation between exposure to oral contraceptives and hyperprolactinemia (46, 47) . Yet, it can be argued that the inclusion of progesterone in most oral contraceptives may have averted a distinct estrogenic effect. Certainly, the observed discrepancy between the effects of BPA or OP and DES on the neuroendocrine axis suggest dissimilarity of action of the various estrogenic compounds. At present, there is no information about whether exposure of pregnant women or infants to xenoestrogens increases serum PRL levels or affects fertility, nor is it known whether humans are sufficiently exposed to such compounds to warrant concern. Future research, using a variety of experimental models, should help resolve these issues.
